Affiliation:
1. Department of Propedeutic of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, Clinic of Rheumatology, University General Hospital “Sveti Georgi”, 4001 Plovdiv, Bulgaria
2. Department of Propedeutic of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, University General Hospital “Kaspela”, 4001 Plovdiv, Bulgaria
Abstract
This retrospective case-control study examined the relationship between the serum and synovial levels of cathepsin G (CatG) and cathepsin K (CatK) in patients with psoriatic arthritis (PsA) and their association with disease activity. Methods: This case-control study involved 156 PsA patients, 50 patients with gonarthrosis (GoA), and 30 healthy controls. The target parameters were measured using enzyme-linked immunosorbent assay (ELISA) kits. The serum levels of CatG and CatK were found to be significantly higher in PsA patients compared to both control groups (p < 0.001). Moreover, they could distinguish PsA patients from healthy controls with 100% accuracy. Synovial fluid CatG and CatK were positively associated with the following indicators of disease activity: the VAS (rs = 0.362, rs = 0.391); the DAPSA (rs = 0.191, rs = 0.182); and the mCPDAI (rs = 0.378, rs = 0.313). Our results suggest that serum and synovial fluid CatG and CatK levels could serve as biomarkers for PsA. In PsA patients with synovial fluid crystals, elevated synovial CatG levels demonstrated a sensitivity of 89.54% and a specificity of 86.00% in distinguishing them from PsA patients without crystals. Similarly, elevated synovial CatK levels had a sensitivity of 93.67% and a specificity of 94.34% for distinguishing PsA patients with synovial fluid crystals from those without. Furthermore, the synovial fluid levels of both CatG and CatK showed positive associations with key indicators of disease activity, including the visual analog scale (VAS) (rs = 0.362, rs = 0.391), the disease activity in psoriatic arthritis (DAPSA) (rs = 0.191, rs = 0.182), and the modified composite psoriatic disease activity index (mCPDAI) (rs = 0.378, rs = 0.313). In conclusion, our findings suggest that the serum and synovial fluid levels of CatG and CatK hold promise as potential biomarkers for assessing disease activity in psoriatic arthritis.
Reference30 articles.
1. Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation;Hirai;J. Immunol.,2013
2. Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: From insights into molecular functions to clinical implications;Cheng;Cell Biosci.,2023
3. Incidence and prevalence of psoriatic arthritis: A systematic review;Alamanos;J. Rheumatol.,2008
4. Geneva-Popova, M., Popova-Belova, S., Popova, V., and Stoilov, N. (2022). Assessment of Crystals in the Synovial Fluid of Psoriatic Arthritis Patients in Relation to Disease Activity. Diagnostics, 12.
5. Comorbidities associated with psoriatic arthritis: Review and update;Merola;Clin. Immunol.,2020